ArticleScientific reports2026
Phytochemical profile and in vitro antimicrobial, antiviral, and anticancer activities of Echium angustifolium ethanolic extract.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Echium angustifolium is traditionally valued for its therapeutic properties; yet comprehensive studies on its biological activities are limited. Aerial flowering parts were sequentially extracted with solvents of varying polarity. Extracts were analyzed for yield, phytochemical composition, and total phenolic and flavonoid contents and HPLC. LC-MS/MS analysis in negative ion mode was performed for detailed compound identification. Antioxidant activity was measured using the DPPH assay. Antibacterial activity against Gram-positive and Gram-negative bacteria was evaluated via agar diffusion and MIC/MBC methods. Anti-inflammatory potential was determined in vitro through RBC membrane stabilization (hemolysis) assay. Cytotoxicity and antiviral activity were examined using MTT and cell-based assays on HepG2 and Vero cells. The molecular mechanism of anticancer activity was investigated through qPCR analysis of apoptosis-related genes (Bax, Caspase-3, Caspase-9, and Bcl-2) in HepG2 cells. Antiviral efficacy against Hepatitis A virus (HAV) and Coxsackievirus B4 (CoxB4) was further validated by RT-qPCR quantification of viral RNA copy numbers. The ethanolic extract showed the highest yield (14.23%) among the tested solvents and richest phytochemical profile, with rutin as the predominant compound. LC-MS/MS identified 24 compounds including threonic acid, hypoxanthine, indole-3-carboxylic acid, N-methyllysine, 4-methyl-2-oxovaleric acid, 4-isopropylbenzoic acid, methionine, N-2-fluorenylacetamide, arachidic acid, N-methylanthranilic acid, carbocysteine, fructose-1,6-bisphosphate, lumazine, 5-aminoimidazole-4-carboxamide, and 3-isochromanone. It exhibited significant antioxidant activity (IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.